What Is HCC Gap Analysis

HCC gap analysis is the systematic process of comparing what a member's RAF score should be — based on their complete clinical picture — against what has actually been captured in the current payment year's documented diagnoses. The difference between expected and actual HCC capture represents the gap: conditions that are clinically present but not reflected in the member's risk score.

The CMS-HCC model resets annually, requiring every chronic condition to be re-documented through a qualified face-to-face encounter. This annual reset means that even perfectly captured conditions from the prior year will fall off the RAF score if not recaptured. Gap analysis identifies these recapture failures, along with newly suspected conditions and coding specificity issues, before the payment year closes.

Recapture Gap Impact

Industry data shows that 15-25% of prior-year HCCs are not recaptured annually. For a plan with an average of 3.2 HCCs per member, this represents 0.5-0.8 missed HCCs per member — translating to significant per-member revenue loss.

Targeted Closure

Plans with systematic gap analysis and targeted outreach achieve recapture rates above 90%, compared to 70-75% for plans relying on organic provider documentation without gap-driven intervention.

Identifying Risk Capture Gaps

Gap identification requires comparing multiple data signals to build a complete picture of which conditions are likely present but uncaptured. Patient risk stratification provides the analytical foundation for this comparison.

  • Recapture Gaps: The most straightforward gap type — conditions captured in the prior payment year that have not been re-documented in the current year. These are chronic conditions where the clinical status is unchanged, but the annual documentation requirement has not been met. Diabetes, COPD, heart failure, and chronic kidney disease are the most common recapture gap conditions.
  • Suspect Condition Gaps: Conditions suggested by treatment patterns, pharmacy claims, or lab results that have never been formally diagnosed and coded. A member receiving metformin without a documented diabetes diagnosis, or a member with sustained eGFR below 60 without a CKD diagnosis, represents a suspect condition gap.
  • Specificity Gaps: Conditions that are documented but coded at insufficient specificity to map to an HCC under V28. An unspecified diabetes code that does not trigger an HCC when a more specific code — supported by the same clinical documentation — would qualify is a specificity gap, not a clinical gap.
  • Interaction Gaps: Members with multiple chronic conditions where the individual HCCs are captured but the disease interaction factor is not triggered because one of the required conditions is missing from current-year documentation. Closing a single gap can unlock interaction revenue that exceeds the individual HCC coefficient.
  • New Member Gaps: Members who enrolled during the current year and have limited encounter history with the plan. Their clinical complexity may be significantly higher than what first-year claims data reveals, creating a systematic understatement of risk for the newest members in the population.

Data Sources for Gap Analysis

Effective gap analysis requires triangulating across multiple data sources. No single source provides a complete picture — each reveals different aspects of the member's clinical status and capture opportunities.

  • Prior-Year Claims and Encounters: The foundation of recapture gap identification. Compare prior-year accepted HCCs against current-year submitted diagnoses to identify every chronic condition that has not been re-documented. This comparison should be run at least monthly throughout the payment year.
  • Pharmacy Claims: Active prescriptions for condition-specific medications reveal conditions that are being treated regardless of whether they appear in diagnosis data. Pharmacy-based suspect algorithms can identify gaps for diabetes, cardiovascular disease, mental health conditions, HIV, and dozens of other HCC-mapped conditions.
  • Laboratory Results: Lab values like HbA1c, eGFR, liver function panels, and lipid profiles provide clinical evidence of conditions that may not be coded. Elevated HbA1c above 6.5% strongly suggests diabetes; eGFR below 60 indicates chronic kidney disease. Lab-based gap identification adds clinical validity to suspect conditions.
  • CMS Model Output Reports: MOR data provides the official CMS-accepted RAF scores and HCC profiles for each member. Comparing your internal calculations against MOR data identifies discrepancies where submitted data was not accepted — revealing systematic issues in data submission workflows.
  • EHR Problem Lists: While problem lists are not sufficient for HCC submission, they indicate conditions that providers have identified but may not have fully documented during encounters. Problem list conditions that do not appear in claims data represent documentation gaps that targeted provider outreach can address.
  • Health Risk Assessments: Member-reported health conditions from HRAs, particularly for new enrollees, provide early signals of clinical complexity that may not appear in claims data for months. Population health programs that incorporate HRA data into gap analysis identify high-complexity members earlier.
Automate Gap Identification: Our RAF Score tools identify HCC gaps at the member level, prioritize by revenue impact, and track closure rates in real time. Explore RAF Score tools →

Prioritizing Gaps by Revenue Impact

Not all gaps are worth the same investment to close. Effective gap analysis includes a prioritization framework that directs limited outreach resources toward the highest-return opportunities.

  • Coefficient Value: Rank gaps by the HCC coefficient under V28. A missed HCC with a coefficient of 0.352 (e.g., heart failure) generates approximately $3,660 in annual revenue when closed, while a lower-coefficient HCC generates proportionally less. Focus outreach on high-coefficient gaps first.
  • Confidence Score: Assign a confidence score to each gap based on the strength of evidence. A recapture gap for a condition documented in three prior years with active medication has near-100% confidence. A suspect condition based solely on a single pharmacy claim has lower confidence. High-confidence gaps yield higher closure rates per outreach attempt.
  • Closability: Assess the practical likelihood of closing each gap. A member with a scheduled appointment next month at a participating provider is highly closable. A member who has not been seen in 14 months with no scheduled visits has lower closability without significant outreach investment.
  • Interaction Multiplier: Gaps that unlock disease interaction factors when closed generate revenue beyond the individual HCC coefficient. Identify members where a single gap closure triggers interaction bonuses — these are disproportionately valuable targets.
  • Time Remaining: Gaps identified early in the payment year have more closure pathways available than those identified in the final quarter. Adjust prioritization as the year progresses — in Q4, focus exclusively on members with upcoming scheduled visits or high-certainty retrospective review candidates.

Closing Gaps Through Targeted Outreach

Identifying gaps without a systematic closure process produces analysis that sits in reports rather than generating revenue. The outreach strategy must match the gap type and the member's care engagement pattern.

  • Provider Suspect Lists: Deliver condition-specific suspect lists to providers before scheduled visits. The list should include the suspected condition, supporting evidence (prior diagnoses, medications, lab values), the HCC mapping, and documentation requirements. Providers who receive actionable, evidence-based suspect lists close gaps at 3-4x the rate of those who receive generic coding reminders.
  • Annual Wellness Visit Scheduling: AWVs are the single most effective gap closure vehicle. Proactively schedule AWVs for members with multiple open gaps, particularly in Q1-Q2 when the full payment year is available for recapture. Target 80%+ AWV completion for members with three or more open HCC gaps.
  • Care Management Integration: Embed gap closure into existing care management workflows. When care managers contact high-risk members for medication management, transition of care, or chronic disease management, include gap closure objectives in the outreach protocol.
  • In-Home Health Assessments: Deploy in-home assessments for members who are not engaging with office-based care — homebound members, members in underserved areas, or members who have not been seen in over 12 months. In-home visits can close 4-6 gaps per visit for complex members.
  • Telephonic and Digital Outreach: For lower-priority gaps or members who are difficult to engage, telephonic outreach from clinical staff can schedule appointments, confirm conditions, and prompt members to discuss specific conditions at their next visit. Digital reminders through patient portals supplement telephonic efforts.
  • Retrospective Chart Review: For gaps where clinical documentation exists in the medical record but was not captured in submitted claims, targeted chart review can recover HCCs without requiring additional patient encounters. This approach is most effective for specificity gaps and coding omissions.

Measuring Gap Closure Success

Track gap closure metrics throughout the payment year to assess program effectiveness and adjust strategy in real time.

  • Overall Recapture Rate: The percentage of prior-year HCCs successfully recaptured in the current year. Target: 90% for chronic conditions by end of payment year. Track monthly to identify recapture velocity — are gaps being closed early or concentrating in Q4?
  • Gap Closure Rate by Channel: Measure the closure rate for each outreach channel — provider suspect lists, AWVs, in-home assessments, chart reviews, and care management contacts. This reveals which channels are most effective and where additional investment would yield the highest return.
  • Revenue Impact per Gap Closed: Calculate the actual RAF-driven revenue generated by each closed gap. This metric validates the prioritization framework — if low-priority gaps are generating equal revenue to high-priority gaps, the prioritization model needs recalibration.
  • Time to Closure: Track the elapsed time between gap identification and gap closure. Shorter time-to-closure means revenue is recognized earlier in the payment year. Gaps that persist for more than 90 days after identification should trigger escalated outreach protocols.
  • Provider-Level Performance: Aggregate gap closure rates by attributed provider. Identify high-performing providers whose practices can be modeled for the network, and low-performing providers who need additional education, suspect list delivery improvements, or workflow changes.
  • Population RAF Trend: Monitor the overall population RAF score trajectory throughout the year. A steadily increasing RAF through Q1-Q3 with stabilization in Q4 indicates healthy gap closure velocity. A flat or declining RAF despite active outreach signals systemic issues in the closure workflow.
Key Insight: HCC gap analysis is not a once-a-year exercise — it is a continuous operational discipline. The most effective programs run gap analysis in near-real-time, updating as new claims arrive and trigger immediate outreach for high-priority gaps. Under V28, where the reduced code set means fewer mapping pathways exist, every gap has outsized revenue significance. Organizations that build systematic, data-driven gap closure programs will consistently outperform those relying on organic provider documentation alone.

Ready to Close Your HCC Gaps?

See how our risk intelligence platform identifies, prioritizes, and tracks HCC gaps across your entire membership with real-time analytics and targeted outreach workflows.

Schedule a Demo